Brochure
27 Jul 2023

Drug product capabilities and expertise overview

PDF 668 kB

Drug formulations, Expertly finished - From pre-formulation registration batches and clinical supply to commercial manufacturing and packaging, Cambrex delivers your complex dosage forms with expertise.

Content provided by our supplier

Cambrex

  • US
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer

Other Content from Cambrex (6)

  • News CPHI Pharma Awards 2023 – API Development and Innovation Winners: Snapdragon Chemistry, a Cambrex Company

    After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. 
  • Video Our Corporate Video

    Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,400 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. 


  • Sponsored Content Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

    East Rutherford, NJ – May 31, 2023 – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, invitro diagnosis companies, hospitals and universities with analytical services for blood investigations and hemocompatibility testing.
  • Brochure Drug substance capabilities and expertise overview

    Active ingredients, Dynamic people - From laboratory scale to commercial supply, enjoy working with the experts at Cambrex on your API.
  • News CPHI North America 2023: from the experts - Cambrex

    Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this region of the world.    

  • Brochure Analytical capabilities and expertise overview

    Analytical solutions, Quality assured - Trust our analytical development and testing experts to rapidly advance your molecule for the greatest chance of success.